The Latest Cardiac and Vascular News
WEST CHESTER, Pa., Jan. 4, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce the final closing of their $5.95M Series A financing, which includes conversion of all existing convertible notes. The A round was led by Florida based New World Angels (https://www.newworldangels.com/), followed by DeepWork Capital (https://www.deepworkcapital.com/) and Ocean Azul Partners (https://oceanazulpartners.com/). VESTECK received significant support […]
HOUSTON–(BUSINESS WIRE)–Saranas announces today the closing of the company’s two largest Integrated Delivery Network (IDN) contracts and agreements signed to date: CommonSpirit Health and the Department of Defense. CommonSpirit Health, encompassing all Catholic Health Initiative (CHI) and Dignity Health hospitals, has awarded Saranas a multi-year contract for the use of […]
MORRISVILLE, N.C., Jan. 03, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced Dr. Roger Jeffs has been appointed as Chief Executive Officer (CEO) effective January 3, 2022 and will continue as a director on the board. He succeeds Damian deGoa who will remain a director of the Company […]
– Addition to management team brings experienced strategic legal counsel as Company nears pivotal milestones – ANN ARBOR, Mich., Jan. 04, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR), today announced the appointment of Benjamin O. Looker as general counsel as of January 1, 2022. Mr. Looker will serve as a […]
DURHAM, N.C., Dec. 31, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the appointment of Surgical Key Opinion Leaders (KOLs) Alan P. Kypson, M.D., FACS; Luigi Pascarella, M.D., FACS; and Todd E. Rasmussen, M.D., […]
Acarix AB (”Acarix” or the “Company”) has, as previously announced, completed the rights issue of shares amounting to approximately SEK 79.3 million (the ”Rights Issue”), which was announced on 5 November 2021 and the outcome of the Rights Issue was announced on 20 December 2021. In connection herewith, the board […]
To date, the foundation has funded $15 million of research into congenital heart defects–America’s most common birth defect. NORTHBROOK, Ill., Dec. 28, 2021 /PRNewswire/ — The Children’s Heart Foundation (CHF), the nation’s leading organization dedicated to funding congenital heart defect (CHD) research, will fund over $1,000,000 of research and scientific collaborations in 2021. Every 15 minutes […]
Upon completion, the facility shall produce pathbreaking Transcatheter Heart Valve Technologies for all kinds of Valve diseases for the world market. NEW DELHI and HECHNIGEN, Germany, Dec. 28, 2021 /PRNewswire/ — Translumina, a global developer and manufacturer of innovative cardiovascular medical devices used in interventional cardiology, performed the foundation stone laying ceremony of Asia’s Largest Heart […]
Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker “HYPR” on the Nasdaq Global Market – Business combination results in over $160 million in gross cash proceeds to Hyperfine – Funds to catalyze commercial expansion of the world’s first FDA-cleared portable […]
Commercial Medical Device Veteran to Lead Rollout of HeartBeam Platform Technology SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology to bring new capabilities to cardiovascular disease, has appointed Alan Baumel as Chief Operating Officer. For over 35 years, Mr. […]
